AdAlta Limited (1AD.AX)
AUD 0.02
(-6.25%)
AUD 0.02
(-6.25%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 2.49 Million AUD | -32.62% |
| 2023 | 4.01 Million AUD | 0.27% |
| 2022 | 4 Million AUD | 137.21% |
| 2021 | 1.68 Million AUD | -22.99% |
| 2020 | 2.19 Million AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 FY | 1.61 Million AUD | -59.76% |
| 2024 Q2 | 2 Million AUD | 0.0% |
| 2024 Q4 | 2.49 Million AUD | 0.0% |
| 2023 Q2 | 4.01 Million AUD | 0.0% |
| 2023 FY | 4.01 Million AUD | 0.27% |
| 2023 Q4 | 4.01 Million AUD | 0.0% |
| 2022 Q2 | 2.4 Million AUD | 0.0% |
| 2022 Q4 | 4 Million AUD | 0.0% |
| 2022 FY | 4 Million AUD | 137.21% |
| 2021 Q2 | - AUD | 0.0% |
| 2021 Q4 | 1.68 Million AUD | 0.0% |
| 2021 FY | 1.68 Million AUD | -22.99% |
| 2020 Q2 | 965.8 Thousand AUD | 0.0% |
| 2020 FY | 2.19 Million AUD | 0.0% |
| 2020 Q4 | 2.19 Million AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 Q3 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q1 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -1914.079% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | 55.876% |
| Biome Australia Limited | 1.3 Million AUD | -91.049% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | -261.691% |
| Imugene Limited | 1.54 Million AUD | -61.259% |
| Noxopharm Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 1.11 Million AUD | -124.171% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | -654.815% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | -688.432% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.986% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | -183.542% |
| Starpharma Holdings Limited | 3.52 Million AUD | 29.293% |
| Nanollose Limited | 42.53 Thousand AUD | -5765.408% |
| Memphasys Limited | 4.41 Million AUD | 43.475% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 1.56 Million AUD | -59.732% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | -491.172% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | 85.7% |
| Dimerix Limited | 149.68 Thousand AUD | -1566.561% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 1.22 Million AUD | -103.096% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -1468.46% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 1.48 Million AUD | -67.758% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | 7130.00 AUD | -34886.788% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 23.59 Thousand AUD | -10473.745% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -942.309% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | -207.518% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | -1324.233% |
| Actinogen Medical Limited | 319.06 Thousand AUD | -681.824% |
| Immuron Limited | 173.49 Thousand AUD | -1337.81% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |